Amgen Inc (NASDAQ:AMGN)

139.38
Data as of Aug 29
 +0.69 / +0.50%
Today’s Change
105.76
Today|||52-Week Range
139.73
+22.18%
Year-to-Date
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
Aug 29 / Zacks.com
Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog
Aug 26 / Zacks.com
Amgen Submits Regulatory Application for PCSK9 Inhibitor - Analyst Blog
Aug 29 / Zacks.com
VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
Aug 26 / Zacks.com
OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog
Aug 29 / Zacks.com
New Lifetime High Today: Amgen (AMGN)
Aug 26 / TheStreet.com
Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
Aug 29 / Zacks.com
3 Reasons Amgen Inc.'s Stock Could Fall
Aug 26 / MotleyFool.com
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
Aug 29 / Zacks.com
3 Reasons Celgene Corporation's Stock Could Fall
Aug 26 / MotleyFool.com
What Makes OncoMed Pharmaceuticals (OMED) a Strong Sell? - Tale of the Tape
Aug 29 / Zacks.com
'Fast Money' Recap: Next Stop, S&P 2,100?
Aug 26 / TheStreet.com
Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog
Aug 28 / Zacks.com
Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
Aug 25 / Zacks.com
Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog
Aug 28 / Zacks.com
3 Stocks Reiterated As A Buy: BMY, AXP, AMGN
Aug 25 / TheStreet.com
MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog
Aug 28 / Zacks.com
Zacks Rank #1 Additions for Monday - Tale of the Tape
Aug 25 / Zacks.com
BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study - Analyst Blog
Aug 28 / Zacks.com
Kindred Biosciences Falls on Disappointing CereKin Data - Analyst Blog
Aug 25 / Zacks.com
Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
Aug 28 / Zacks.com
3 Reasons Gilead Science, Inc.bs Stock Could Rise
Aug 20 / MotleyFool.com
3 Health Care Stocks Pushing The Sector Higher
Aug 28 / TheStreet.com
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Aug 20 / Zacks.com
Stocks Hitting 52-Week Highs
Aug 28 / Benzinga
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains ...
Aug 20 / Zacks.com
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
Aug 27 / Benzinga
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
Aug 19 / Zacks.com
Why Amgen (AMGN) Stock Hit a One-Year High Today
Aug 27 / TheStreet.com
3 Reasons Amgen, Inc.'s Stock Could Rise
Aug 18 / MotleyFool.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
Aug 27 / Zacks.com
Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog
Aug 18 / Zacks.com
7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
Aug 26 / MotleyFool.com
Offshore drillers sink after downgrade
Aug 04 / FT.com
Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog
Aug 26 / Zacks.com
WWE slams workers by axing 7% of jobs
Jul 31 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.